muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and...
FDA Device Recall #Z-1069-2025 — Class II — April 22, 2024
Recall Summary
| Recall Number | Z-1069-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 22, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Murata Vios, Inc. |
| Location | Woodbury, MN |
| Product Type | Devices |
| Quantity | 62 units |
Product Description
muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate
Reason for Recall
During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only occurs on the Central Station Monitor (CSM) in the patient tiles view and is not seen at any other point during patient monitoring & not on the Bedside Monitor.
Distribution Pattern
Worldwide - US Nationwide distribution in the states of NY, TX, OH, MD and the country of India.
Lot / Code Information
Soft ware version 1.57.20, UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y
Other Recalls from Murata Vios, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1292-2025 | Class II | Vios Monitoring System Bedside Monitor Model BS... | Aug 9, 2024 |
| Z-1169-2025 | Class II | Vios Monitoring System Bedside Monitor, Model B... | Jun 6, 2023 |
| Z-0956-2025 | Class II | muRata Vios Monitoring System Model 2050; bedsi... | Jun 21, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.